Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

258 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic significance of pretreatment PET parameters in inoperable, node-positive NSCLC patients with poor prognostic factors undergoing hypofractionated radiotherapy: a single-institution retrospective study.
Zinn AB, Kenndoff S, Holzgreve A, Käsmann L, Guggenberger JE, Hering S, Mansoorian S, Schmidt-Hegemann NS, Reinmuth N, Tufman A, Dinkel J, Manapov F, Belka C, Eze C. Zinn AB, et al. Among authors: eze c. EJNMMI Rep. 2024 Oct 8;8(1):32. doi: 10.1186/s41824-024-00220-w. EJNMMI Rep. 2024. PMID: 39375264 Free PMC article.
Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis.
Eze C, Taugner J, Roengvoraphoj O, Schmidt-Hegemann NS, Käsmann L, Wijaya C, Belka C, Manapov F. Eze C, et al. Radiat Oncol. 2019 Sep 4;14(1):163. doi: 10.1186/s13014-019-1304-2. Radiat Oncol. 2019. PMID: 31484542 Free PMC article.
Pooled analysis on image-guided moderately hypofractionated thoracic irradiation in inoperable node-positive/recurrent patients with non-small cell lung cancer with poor prognostic factors and severely limited pulmonary function and reserve.
Eze C, Guggenberger JE, Schmidt-Hegemann NS, Kenndoff S, Taugner J, Käsmann L, Schönecker S, Flörsch B, Li M, Belka C, Manapov F. Eze C, et al. Cancer. 2022 Jun 15;128(12):2358-2366. doi: 10.1002/cncr.34201. Epub 2022 Apr 13. Cancer. 2022. PMID: 35417563 Free article.
Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.
Gennen K, Käsmann L, Taugner J, Eze C, Karin M, Roengvoraphoj O, Neumann J, Tufman A, Orth M, Reu S, Belka C, Manapov F. Gennen K, et al. Among authors: eze c. Radiat Oncol. 2020 Jan 2;15(1):5. doi: 10.1186/s13014-019-1453-3. Radiat Oncol. 2020. PMID: 31898519 Free PMC article.
PSMA-positive nodal recurrence in prostate cancer : Salvage radiotherapy is superior to salvage lymph node dissection in retrospective analysis.
Schmidt-Hegemann NS, Buchner A, Eze C, Rogowski P, Schaefer C, Ilhan H, Li M, Fendler WP, Bartenstein P, Ganswindt U, Stief C, Belka C, Kretschmer A. Schmidt-Hegemann NS, et al. Among authors: eze c. Strahlenther Onkol. 2020 Jul;196(7):637-646. doi: 10.1007/s00066-020-01605-z. Epub 2020 Mar 24. Strahlenther Onkol. 2020. PMID: 32211942 Free PMC article.
258 results